Listed

Amneal Pharmaceuticals, Inc.

AMRXNasdaqCIK 1723128HealthcareFiscal year ends Dec 31

Reports and events: 191 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Amneal Pharmaceuticals, Inc., Reports and events
FiledFormWhat it isAccession number
2024-08-0906:14 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001723128-24-000030
2024-05-1316:15 ETSC 13D/AOwnership report, active investor, amended0000898432-24-000401
2024-05-0816:46 ET10-QQuarterly reportPeriod 2024-03-310001723128-24-000021
2024-05-0716:18 ET8-K5.07 Shareholder vote results0001628280-24-021107
2024-05-0306:14 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001723128-24-000018
2024-03-2208:01 ETDEF 14AProxy statementPeriod 2024-05-020001308179-24-000231
2024-03-1417:04 ET10-KAnnual reportPeriod 2023-12-310001723128-24-000014
2024-03-0106:13 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001723128-24-000007
2024-01-1007:03 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure0001723128-24-000003
2024-01-0316:30 ETSC 13D/AOwnership report, active investor, amended0000898432-24-000009
2023-12-1516:15 ET8-K3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-23-296658
2023-12-1516:06 ET8-K/A9.01 Financial statements and exhibits0001193125-23-296632
2023-12-0116:15 ETSC 13D/AOwnership report, active investor, amended0000898432-23-000828
2023-11-1417:04 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-23-277184
2023-11-0918:51 ET10-QQuarterly reportPeriod 2023-09-300001723128-23-000044
2023-11-0817:07 ETSC 13D/AOwnership report, active investor, amended0001193125-23-273628
2023-11-0817:05 ETSC 13D/AOwnership report, active investor, amended0001193125-23-273625
2023-11-0817:03 ETSC 13D/AOwnership report, active investor, amended0001193125-23-273619
2023-11-0816:59 ETSC 13D/AOwnership report, active investor, amended0001193125-23-273614
2023-11-0816:55 ETSC 13D/AOwnership report, active investor, amended0001193125-23-273607
2023-11-0706:21 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001723128-23-000038
2023-10-2316:16 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001723128-23-000035
2023-10-1819:32 ETSC 13D/AOwnership report, active investor, amended0001193125-23-257893
2023-10-1819:31 ETSC 13D/AOwnership report, active investor, amended0001193125-23-257891
2023-10-1819:30 ETSC 13D/AOwnership report, active investor, amended0001193125-23-257890
2023-10-1819:27 ETSC 13D/AOwnership report, active investor, amended0001193125-23-257885
2023-10-1819:25 ETSC 13D/AOwnership report, active investor, amended0001193125-23-257880
2023-10-1706:51 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-23-257254
2023-08-0816:54 ET10-QQuarterly reportPeriod 2023-06-300001723128-23-000031
2023-08-0406:22 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001723128-23-000027
2023-05-1916:06 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-149302
2023-05-1216:29 ET8-K5.07 Shareholder vote results0001723128-23-000023
2023-05-0916:53 ET10-QQuarterly reportPeriod 2023-03-310001723128-23-000020
2023-05-0506:17 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001723128-23-000017
2023-04-1706:43 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001723128-23-000012
2023-03-2408:01 ETDEF 14AProxy statement0001308179-23-000351
2023-03-0317:08 ET10-KAnnual reportPeriod 2022-12-310001723128-23-000009
2023-03-0206:27 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001723128-23-000006
2023-01-1006:05 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure0001193125-23-005141
2022-12-1417:05 ETSC 13D/AOwnership report, active investor, amended0001387131-22-012413
2022-11-0716:20 ET10-QQuarterly reportPeriod 2022-09-300001723128-22-000039
2022-11-0406:24 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001723128-22-000037
2022-09-0616:15 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-238857
2022-08-0816:42 ET10-QQuarterly reportPeriod 2022-06-300001723128-22-000034
2022-08-0506:11 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001723128-22-000028
2022-08-0308:17 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-210639
2022-07-1907:00 ET8-K8.01 Other events0001193125-22-196582
2022-06-0217:24 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001723128-22-000023
2022-05-1316:39 ET8-K5.07 Shareholder vote results0001723128-22-000019
2022-05-0616:39 ET10-QQuarterly reportPeriod 2022-03-310001723128-22-000016

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 02:45 ET. Listed shows no prices and gives no investment advice.